BRIEF published on 06/11/2026 at 07:05, 18 days 16 hours ago Biosynex finalizes the sale of its molecular biology business Restructuring Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 06/11/2026 at 07:05, 18 days 16 hours ago Biosynex finalise la cession de son activité de biologie moléculaire Cession Restructuration BIOSYNEX Biologie Moléculaire Diagnostic Rapide
BRIEF published on 06/11/2026 at 07:05, 18 days 16 hours ago Biosynex cède son activité de biologie moléculaire Cession Croissance Stratégique BIOSYNEX Biologie Moléculaire Diagnostic Rapide
BRIEF published on 06/11/2026 at 07:05, 18 days 16 hours ago Biosynex sells its molecular biology business Strategic Growth Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
PRESS RELEASE published on 06/11/2026 at 07:00, 18 days 16 hours ago BIOSYNEX SA: BIOSYNEX ANNONCE LA REALISATION DEFINITIVE DE LA CESSION DE SON ACTIVITE DE BIOLOGIE MOLECULAIRE Biosynex finalise la cession de son activité de biologie moléculaire avec levée des conditions suspensives. Larry Abensur commente le recentrage stratégique Stratégie Cession BIOSYNEX Biologie Moléculaire Larry Abensur
PRESS RELEASE published on 06/11/2026 at 07:00, 18 days 16 hours ago BIOSYNEX SA: BIOSYNEX ANNONCE LA REALISATION DEFINITIVE DE LA CESSION DE SON ACTIVITE DE BIOLOGIE MOLECULAIRE Biosynex annonce la réalisation de la cession de son activité de biologie moléculaire. Larry Abensur commente sur la stratégie future de la société Stratégie Cession BIOSYNEX Biologie Moléculaire Larry Abensur
BRIEF published on 05/25/2026 at 08:05, 1 month 4 days ago BIOSYNEX Envisage la Cession de son Activité de Biologie Moléculaire Stratégie Cession Industrie Pharmaceutique BIOSYNEX Biologie Moléculaire
BRIEF published on 05/25/2026 at 08:05, 1 month 4 days ago BIOSYNEX is considering the sale of its Molecular Biology business Pharmaceutical Industry Strategy Transfer BIOSYNEX Molecular Biology
BRIEF published on 05/25/2026 at 08:05, 1 month 4 days ago Biosynex cède son activité de biologie moléculaire Cession BIOSYNEX Conditions Suspensives Biologie Moléculaire Industriel Pharmaceutique
BRIEF published on 05/25/2026 at 08:05, 1 month 4 days ago Biosynex sells its molecular biology business Transfer BIOSYNEX Molecular Biology Conditions Precedent Pharmaceutical Manufacturer
Published on 06/29/2026 at 22:01, 1 hour 30 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 8 hours 31 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 8 hours 31 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 9 hours 1 minute ago Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 14:30, 9 hours 1 minute ago Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 22:47, 44 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 1 hour 26 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 1 hour 26 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 3 hours 1 minute ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 3 hours 31 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 5 hours 1 minute ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 5 hours 1 minute ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 5 hours 46 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 5 hours 46 minutes ago Déclaration hebdomadaire de rachat d'actions
